PetMed Express Inc (PETS)
4.645
+0.06
(+1.42%)
USD |
NASDAQ |
Nov 21, 16:00
4.645
0.00 (0.00%)
After-Hours: 20:00
PetMed Express Enterprise Value: 42.60M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 42.60M |
| November 19, 2024 | 41.57M |
| November 18, 2024 | 40.33M |
| November 15, 2024 | 45.08M |
| November 14, 2024 | 52.73M |
| November 13, 2024 | 56.96M |
| November 12, 2024 | 54.79M |
| November 11, 2024 | 59.96M |
| November 08, 2024 | 62.85M |
| November 07, 2024 | 66.36M |
| November 06, 2024 | 35.16M |
| November 05, 2024 | 36.09M |
| November 04, 2024 | 35.16M |
| November 01, 2024 | 34.54M |
| October 31, 2024 | 32.68M |
| October 30, 2024 | 31.24M |
| October 29, 2024 | 32.27M |
| October 28, 2024 | 33.72M |
| October 25, 2024 | 27.93M |
| October 24, 2024 | 27.52M |
| October 23, 2024 | 28.55M |
| October 22, 2024 | 32.68M |
| October 21, 2024 | 28.96M |
| October 18, 2024 | 30.20M |
| October 17, 2024 | 30.00M |
| Date | Value |
|---|---|
| October 16, 2024 | 31.65M |
| October 15, 2024 | 32.68M |
| October 14, 2024 | 30.62M |
| October 11, 2024 | 28.55M |
| October 10, 2024 | 27.72M |
| October 09, 2024 | 30.20M |
| October 08, 2024 | 31.24M |
| October 07, 2024 | 26.07M |
| October 04, 2024 | 28.34M |
| October 03, 2024 | 33.30M |
| October 02, 2024 | 28.34M |
| October 01, 2024 | 24.42M |
| September 30, 2024 | 24.00M |
| September 27, 2024 | 29.83M |
| September 26, 2024 | 29.00M |
| September 25, 2024 | 27.15M |
| September 24, 2024 | 26.53M |
| September 23, 2024 | 25.91M |
| September 20, 2024 | 26.12M |
| September 19, 2024 | 31.89M |
| September 18, 2024 | 28.59M |
| September 17, 2024 | 29.62M |
| September 16, 2024 | 27.56M |
| September 13, 2024 | 27.97M |
| September 12, 2024 | 27.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.58M
Minimum
Aug 12 2024
943.55M
Maximum
Jan 27 2021
339.26M
Average
355.10M
Median
Enterprise Value Benchmarks
| TruBridge Inc | 414.25M |
| Streamline Health Solutions Inc | 21.26M |
| R1 RCM Inc | 8.087B |
| LENZ Therapeutics Inc | 715.45M |
| Oruka Therapeutics Inc | 369.02M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.326M |
| Revenue (Quarterly) | 59.57M |
| Total Expenses (Quarterly) | 59.02M |
| EPS Diluted (Quarterly) | 0.11 |
| Gross Profit Margin (Quarterly) | 29.06% |
| Profit Margin (Quarterly) | 3.90% |
| Earnings Yield | -1.29% |
| Normalized Earnings Yield | -1.292 |